Bexlosteride - CAS 148905-78-6

Bexlosteride (LY300502), a benzoquinolinone derivative, functions as a human type I 5α-reductase inhibitor. It demonstrates metabolic inhibition, antiproliferative, and antisecretory activities specifically in LNCaP human prostatic adenocarcinoma cell cultures, positioning it as a potent agent for prostate cancer research [1] [2].

Reductase, Others

Endocrinology/Hormones, Others, Metabolism

148821

C14H16ClNO

249.74

CN1[C@]2([C@@](C=3C(CC2)=CC(Cl)=CC3)(CCC1=O)[H])[H]

-20°C

Ice Packs

Small Compound